Pharmacokinetics and metabolism of zamifenacin in mouse, rat, dog and man

Xenobiotica

Volumn 26, Issue 4, 1996, Pages 459-471

  Beaumont, K C ^a   Causey, A G ^a,b   Coates, P E ^a   Smith, D A ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b Hazleton Europe   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARALKYLAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DRUG METABOLITE; UNCLASSIFIED DRUG; ZAMIFENACIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG METABOLISM; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RAT; SPECIES DIFFERENCE;

EID: 0030005842     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046724     Document Type: Article

References (9)

1. ANDERS, M. W., and SUNRAM, J. M., 1983, Mechanism of the metabolism of 1,3-benzodioxoles to carbon monoxide. Biochemical Pharmacology, 33, 577-580.
2. BEAUMONT, K. C., MACRAE, P. V., MILLER, C. M., WRIGHT, P. A., and SMITH, D. A., 1994, Pharmacokinetics of zamifenazin in man and animals: species differences in plasma protein binding. British Journal of Clinical Pharmacology, 38, 179P.
3. HADDOCK, R. E., JOHNSON, A. M., LANGLEY, P. F., NELSON, D. R., POPE, J. A., THOMAS, D. R., and WOODS, F. R., 1989, Metabolic pathway of paroxetine in animals and man and the comparative pharmacological profile of its metabolites. Acta Psychiatrica Scandinavica, 80 (suppl. 350), 24-26.
4. KAMIENSKI, F. X., and CASIDA, J. E., 1970, Importance of demethylenation in the metabolism in vivo and in vitro of methylenedioxyphenyl synergists and related compounds in mammals. Biochemical Pharmacology, 19, 91-112.
5. KAYE, C. M., HADDOCK, R. E., LANGLEY, P. F., MELLOWS, G., TASKER, T. C. G., ZUSSMAN, B. D., and GREB, W. H., 1989, A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatrica Scandinavica, 80 (suppl. 350), 60-75.
6. MORELAND, T. A., ASTOIN, J., LEPAGE, F., TOMBRET, F., LEVY, R. H., and BAILLIE, T. A., 1986, The metabolic rate of stiripentol in man. Drug Metabolism and Disposition, 14, 654-662.
7. SCHELINE, R. R., 1973, Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews, 25, 451-523.
8. SMITH, D. A., 1991, Aromatic hydroxylation of arylalkylamines in rodents. Drug Metabolism Reviews, 23, 255.
9. WALLIS, R. M., ALKER, D. A., BURGES, R. A., CROSS, P.E., NEWGREEN, D. T., and QUINN, P., 1993, Zamifenacin: a novel gut-selective muscarinic receptor antagonist. British Journal of Pharmacology, 109, 36P.